NASDAQ: ACRSAclaris Therapeutics Inc Stock Ownership - Who owns Aclaris Therapeutics?
Insider buying vs selling
Have Aclaris Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Neal Walker | INTERIM PRESIDENT AND CEO | 2024-04-01 | 3,224 | $1.26 | $4.06kSell |
| Andrew Kenneth William Powell | Director | 2024-03-04 | 6,000 | $1.25 | $7.50kBuy |
| Kevin Balthaser | Chief Financial Officer | 2024-03-02 | 427 | $1.24 | $529.48Sell |
| Joseph Monahan | Chief Scientific Officer | 2024-03-02 | 3,531 | $1.24 | $4.38kSell |
| Kevin Balthaser | Chief Financial Officer | 2024-03-01 | 313 | $1.24 | $388.12Sell |
| Kevin Balthaser | Chief Financial Officer | 2024-03-01 | 677 | $1.24 | $839.48Sell |
| Andrew Kenneth William Powell | Director | 2024-03-01 | 8,500 | $1.23 | $10.46kBuy |
| Neal Walker | Interim President and CEO | 2024-03-01 | 3,223 | $1.24 | $4.00kSell |
| Joseph Monahan | Chief Scientific Officer | 2024-03-01 | 3,183 | $1.24 | $3.95kSell |
| Joseph Monahan | Chief Scientific Officer | 2024-03-01 | 14,569 | $1.24 | $18.07kSell |
ACRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ACRS insiders and whales buy or sell their stock.
ACRS Shareholders
What type of owners hold Aclaris Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Braden Michael Leonard | 13.25% | 9,395,934 | $10.99M | Insider |
| Fmr LLC | 12.18% | 8,637,727 | $10.11M | Insider |
| Blackrock Inc | 8.33% | 5,905,872 | $6.91M | Institution |
| Citadel Advisors LLC | 7.60% | 5,388,789 | $6.30M | Institution |
| Vanguard Group Inc | 6.66% | 4,722,357 | $5.53M | Institution |
| Ra Capital Management LP | 6.12% | 4,339,299 | $5.08M | Insider |
| Albert Cha | 5.91% | 4,191,397 | $4.90M | Insider |
| James E. Flynn | 5.81% | 4,123,266 | $4.82M | Insider |
| Bain Capital Life Sciences Investors LLC | 4.93% | 3,500,000 | $4.10M | Institution |
| Anand Mehra | 4.92% | 3,489,757 | $4.08M | Insider |
ACRS vs Diagnostic & Research Stocks
Aclaris Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.